Gujarat Themis Biosyn Ltd

NSE: GUJTHEM · BSE: 506879 · Pharmaceuticals & Biotechnology · 67 announcements

Share price: ₹380.55
Market cap: ₹4,953 Cr
Revenue (annual): ₹165.8 Cr
Net profit (annual): ₹46.68 Cr
P/E (TTM): 101.7×Sector 47.4×
Promoter holding: 59.33%-11.53% QoQ
FII holding: 4.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 7 Other Announcement 4 Fund Raise 3 Board Meeting Date 3 Promoter Buying (Off-Market) 2 Legal & Regulatory 2 Financial Results 2 Earnings Call 2 Debt & Borrowing 2 Credit Rating 2 Capital Structure Change 2 Acquisition 2 Dividend 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

13 Jul 2026 21:17 IST BSE

Legal & Regulatory

Gujarat Themis Biosyn Legal & Regulatory

Gujarat Themis Biosyn initiated arbitration against Optimus Drugs claiming Rs. 90.24 Crore. The dispute involves breached 'Take-or-Pay' obligations and terminated supply agreements.

Value: ₹90.24 Cr

Read the filing ↗

13 Jul 2026 20:57 IST BSE

Legal & Regulatory

Gujarat Themis Biosyn Legal & Regulatory

Gujarat Themis Biosyn amicably settled its commercial dispute with Optimus Drugs Private Limited. The arbitration disposal results in no material financial impact or penalties.

Read the filing ↗